Mutational activation of FGFR3 is not involved in the development of prostate cancer.
Koufou S, Lunz JC, Borchardt A, Keck B, Kneitz B, Gaisa NT, Hafner C, Giedl C, Rau TT, Rogler A, Wieland WF, Hartmann A, Stoehr R.
Koufou S, et al. Among authors: wieland wf.
Pathobiology. 2010;77(5):249-52. doi: 10.1159/000317055. Epub 2010 Nov 29.
Pathobiology. 2010.
PMID: 21116115
Free article.